Breaking News, Financial News

4Q Financial Reports: West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc.

4Q Revenue: $195.6 million (+38%)

4Q Earnings: $12.9 million (+77%)

FY Revenues: $699.7 million (+29%)

FY Earnings: $45.2 million (+35%)

Comments: Pharmaceutical systems business sales grew 9.5% to $136.4 million in the quarter and gross profit in the segment was $44 million, or 32% of sales. Monarch Laboratories, acquired in February 2005, and Medimop Medical Projects, acquired in August 2005, are included in the Pharmaceutical Systems segment. Improvement in the segment’s gross margin was a result of production efficiencies, higher margin products and services in the Monarch Labs and Medimop Medical Projects businesses, and lower workers compensation costs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters